WHO ICTRP trial
A Randomized, controlled, open multicenter clinical trial of Recombinant Human…
ChiCTR1800014265 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800014265 |
|---|---|
| Public title | A Randomized, controlled, open multicenter clinical trial of Recombinant Human Erythropoietin Injection (CHO cells) comparing for single and two to three times weekly administration of renal anemia in maintenance hemodialysis |
| Scientific title | A Randomized, controlled, open multicenter clinical trial of Recombinant Human Erythropoietin Injection (CHO cells) comparing for single and two to three times weekly administration of renal anemia in maintenance hemodialysis |
| Primary sponsor | Beijing Friendship Hospital Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Conditions | Renal anemia |
| Interventions | Treatment group:rhEPO 12000IU, once a week, was administered by i.v. injection, for 24 weeks;Control group:rhEPO 4000IU, three times a week, was administered by i.v. injection, for 24 weeks |
| Registration date | Jan 2, 2018 |
| Target size | Treatment group:72;Control group:72 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: